Ong, W., Leow, D. M., Herr, D. R., & Yeo, C. J. (2023). What Do Randomized Controlled Trials Inform Us About Potential Disease-Modifying Strategies for Parkinson’s Disease? NeuroMolecular Medicine, 25(1), 1-13. https://doi.org/10.1007/s12017-022-08718-x
Chicago-referens (17:e uppl.)Ong, Wei-Yi, Damien Meng-Kiat Leow, Deron R. Herr, och Crystal Jing-Jing Yeo. "What Do Randomized Controlled Trials Inform Us About Potential Disease-Modifying Strategies for Parkinson’s Disease?" NeuroMolecular Medicine 25, no. 1 (2023): 1-13. https://doi.org/10.1007/s12017-022-08718-x.
MLA-referens (9:e uppl.)Ong, Wei-Yi, et al. "What Do Randomized Controlled Trials Inform Us About Potential Disease-Modifying Strategies for Parkinson’s Disease?" NeuroMolecular Medicine, vol. 25, no. 1, 2023, pp. 1-13, https://doi.org/10.1007/s12017-022-08718-x.
